Ramberger, Evelyn https://orcid.org/0000-0003-2760-2696
Sapozhnikova, Valeriia
Ng, Yuen Lam Dora
Dolnik, Anna
Ziehm, Matthias https://orcid.org/0000-0001-7074-4054
Popp, Oliver
Sträng, Eric
Kull, Miriam
Grünschläger, Florian https://orcid.org/0000-0003-0021-6912
Krüger, Josefine https://orcid.org/0000-0001-5789-4082
Benary, Manuela https://orcid.org/0000-0002-3067-2030
Müller, Sina https://orcid.org/0009-0003-6363-5599
Gao, Xiang
Murgai, Arunima https://orcid.org/0000-0001-9767-7402
Haji, Mohamed
Schmidt, Annika
Lutz, Raphael
Nogai, Axel
Braune, Jan https://orcid.org/0000-0003-2026-2641
Laue, Dominik https://orcid.org/0000-0002-7237-9414
Langer, Christian
Khandanpour, Cyrus
Bassermann, Florian https://orcid.org/0000-0003-4435-2609
Döhner, Hartmut https://orcid.org/0000-0003-2116-5536
Engelhardt, Monika https://orcid.org/0000-0003-0405-1676
Straka, Christian
Hundemer, Michael https://orcid.org/0000-0002-5596-2405
Beule, Dieter https://orcid.org/0000-0002-3284-0632
Haas, Simon https://orcid.org/0000-0001-9227-2051
Keller, Ulrich https://orcid.org/0000-0002-8485-1958
Einsele, Hermann https://orcid.org/0000-0002-7680-0819
Bullinger, Lars
Knop, Stefan https://orcid.org/0000-0003-1276-6639
Mertins, Philipp https://orcid.org/0000-0002-2245-528X
Krönke, Jan https://orcid.org/0000-0002-4649-0506
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (Emmy-Noether Program Kr3886/ 2-2 and SBF-1074)
Berliner Sparkassenstiftung Medizin
Deutsche Konsortium für Translationale Krebsforschung (DKTK), Berliner Krebsgesellschaft e.V.
Bundesministerium für Bildung und Forschung (031L0220B)
Article History
Received: 21 December 2022
Accepted: 15 May 2024
First Online: 28 June 2024
Competing interests
: J.K. received speaker and/or advisory board honoraria from Bristol-Myers Squibb/Celgene, Sanofi, Abbvie, Takeda, Pfizer and Janssen. S.K. received honoraria from Amgen, Bristol-Myers Squibb, Celgene, Janssen, Takeda, Sanofi and Oncopeptides; served as a consultant or in an advisory role for Amgen, Bristol-Myers Squibb, Celgene, Janssen and Takeda; and received research funding from Amgen, Bristol-Myers Squibb, Celgene, Janssen and Takeda. The other authors declare no competing interests.